Plain-English translation of NCT06888063 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether an implanted chemotherapy pump can help prevent bile duct cancer from coming back after surgery. The pump delivers chemotherapy directly into the blood vessels of the liver, so the medication reaches the cancer site more effectively. Researchers want to see if this approach helps patients live longer and stay cancer-free.
Bile duct cancer inside the liver often comes back after surgery, even when the tumor is removed completely. This trial is exploring whether adding direct chemotherapy to the liver area after surgery can reduce the chance of the cancer returning and help patients survive longer.
You likely qualify if…
You likely don't qualify if…
You would undergo surgery to remove the bile duct cancer, and at the same time, a surgeon would place a small pump device under your skin that delivers chemotherapy directly to your liver. After surgery, you would receive chemotherapy through this pump over several months. You would return to the hospital or clinic regularly for pump refills, blood tests, and scans to monitor how well the treatment is working and check for side effects.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
Netherlands